Clinical Trial Results for Approved Products

This webpage provides summaries (protocol and results) of Taiho-sponsored interventional clinical trials conducted in patients for medicinal products and indications approved by regulatory authorities in the United States, Europe, or Japan on or after January 15, 2018, in accordance with the IFPMA Principles for Responsible Clinical Trial Data Sharing and Taiho clinical trial information disclosure policy.
As the summaries of clinical studies are findings as of completion of each study, please refer to the latest package insert of each region or country regarding detailed information that has received marketing approval from regulatory authorities.
The information in the synopses of CSRs is not intended to replace the advice of a health care professional. If you have any questions regarding specific symptoms, please consult a health care professional.
This webpage has no intention to promote Taiho’s medicines and the indication.

The summaries of each clinical trial are available on clinical trial registries such as the Japan Registry of Clinical Trials (jRCT) and ClinicalTrials.gov. You can access the summaries by searching for each clinical trial using its registry ID.

Generic Name

Condition(s)

Development Stage

Protocol Number

Clinical Trial Registry ID (for accessing clinical trial summaries: protocol and results)

trifluridine and tipiracil hydrochloride

Gastric cancer

Phase 3

TO-TAS-102-302

NCT02500043

fosnetupitant chloride hydrochloride

Chemotherapy-induced nausea and vomiting

 Phase 2

10057020

jRCT2080223300

fosnetupitant chloride hydrochloride

Chemotherapy-induced nausea and vomiting

Phase 3

10057030

jRCT2080224542

fosnetupitant chloride hydrochloride

Chemotherapy-induced nausea and vomiting

Phase 3

10057040

jRCT2080224620

palonosetron hydrochloride

Chemotherapy-induced nausea and vomiting

Phase 3

10037050

jRCT2080223250

pimitespib

Gastrointestinal Stromal Tumor (GIST)

Phase 2

10058020

jRCT2080223127

pimitespib

Gastrointestinal Stromal Tumor (GIST)

Phase 3

10058030

jRCT2080224033

futibatinib

Cholangiocarcinoma
[Japan：Biliary tract cancer]

Phase 1/2

TPU-TAS-120-101

NCT02052778
jRCT2080224117